Panel Discussion: Merck R&D’s Digitally-Enabled Clinical Trial Team

Webcast

***Tuesday, January 12, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET***Merck’s Digitally-Enabled Clinical Trial Initiative Members or “Smart Team” will discuss their experiences introducing digital technologies into the clinical trial paradigm and within their function. *** On demand available after final airing until Jan. 12, 2021 ***

Register Free:
http://www.appliedclinicaltrialsonline.com/act_s/trial_team

Event Overview: Members of Merck’s Digitally-Enabled Clinical Trials Initiative Team will discuss their experiences introducing digital technologies into the clinical trial paradigm. Internally dubbed the “Smart Team” within Merck R&D, members from this cross-functional team, including representatives from Global Digital Analytics & Technologies, Global Clinical Supply, Information Technology, and Pharmacokinetics, Pharmacodynamics, and Drug Metabolism will share the impact of adopting digital technologies within their function.

The discussion will be based on their article, “Digitally-Enabled, Patient-Centric Clinical Trials: Shifting the Drug Development Paradigm,”recently published in Clinical and Translational Sciences.* Registrants are encouraged to preview the paper and email questions for panel members prior to the webcast to the Adherence Measurement Institute at info@adherencemeasurement.org.

*The American Society of Clinical Pharmacology and Therapeutics (ASCPT) has graciously made Merck’s research article available on the Clinical and Translational Science website.

Key Learning Objectives:

  • Attendees will
  • Learn from the panel's experience in pilot testing and clinical trial deployment in the following four key areas:
    • Smart Dosing: Use of technologies that can monitor and improve patient adherence to protocol
    • Patient-Centric Sampling: Collection of pharmacokinetic, pharmacodynamic, and biomarker samples in an outpatient setting
    • Digital Biomarkers: Use of digital devices to collect and measure physiological and behavioral data
    • Digital Platform: Use of data platforms that integrate digital data streams, visualize data in real-time, and provide a means of greater patient engagement during the trial
  • Learn about the change to synergistic power of jointly implementing these approaches within a trial to enable better understanding of patient adherence, safety, efficacy, and PK/PD relationships of investigational therapies as well as reduced patient burden for clinical trial participants.
  • Learn about the challenges to adoption and to the full realization of patient-centric, digitally-enabled trials

SpeakersDr. Lisa Shipley, Vice President of Global Digital and Analytics Technologies, Merck & Co., Inc.

Dr. Marissa Dockendorf, Director of Digital Analytics in the Global Digital Analytics and Technologies, Merck & Co., Inc.

Dr. Kevin Bateman, Scientific Associate Vice President, Merck & Co., Inc.

Dr. Bryan J. Hansen, Associate Principal Scientist in the Global Digital Analytics and Technologies, Merck & Co., Inc.

Matt Moyer, Director of Clinical Supply Technology, Merck & Co., Inc.

Jyoti Shah, Associate Director of Data Science & Scientific Informatics, Merck & Co., Inc.

Moderator: John Musaus, Founder & Executive Director, Adherence Measurement Institute

Time and Date: Tuesday, January 12, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET

On demand available after final airing until Jan. 12, 2021

Register freehttp://www.appliedclinicaltrialsonline.com/act_s/trial_team